BEGIN:VCALENDAR
PRODID:-//github.com/rianjs/ical.net//NONSGML ical.net 4.0//EN
VERSION:2.0
BEGIN:VEVENT
DESCRIPTION:Address Key European Regulatory Challenges and Cutting Edge Pl
 atform Design to Advance Allogeneic Approaches\n\nAllogeneic therapies ar
 e fast becoming the holy grail for cell therapy as they boast the potenti
 al to reduce the cost of goods\, improve accessibility\, reduce turnaroun
 d times and have the ability to treat masses of patients. However\, in Eu
 rope there are critical challenges limiting clinical advancement\, with i
 ncreased complexities with disharmonized European regulations where guida
 nce varies across countries\, and challenges in cross-country logistics w
 hen running multicentric trials.\n\nThe Allogeneic Cell Therapies Summit 
 Europe is the only industry-focused forum dedicated to address the specif
 ic challenges facing European drug developers in order to advance your pi
 peline to clinical and commercial success.\n\nCollaborate with European l
 eaders from Cellectis\, Celyad\, GammaDelta Therapeutics\, Medicines and 
 Healthcare Products Regulatory Agency and more to benchmark best-in-class
  approaches to achieve optimal clinical set up and large scale manufactur
 e for your off-the-shelf product. Ensure you have these important conside
 rations planned early in development to overcome delays and critical push
  backs later in your clinical translation.\n\nJoin your community in Lond
 on this January to take on this next frontier in cell therapy and leave w
 ith cutting-edge strategies to develop safe\, effective and accessible ce
 ll therapies for patients in Europe.\n\nThis is your comprehensive guide 
 to define your commercial path forward developing off-the-shelf products.
 \n\nhttps://allogeneic-cell-therapies-europe.com/18-20 January\, 2022Lond
 on\, UK\n\nContact:info@hansonwade.com\n
DTEND:20220120T180000
DTSTAMP:20260307T144053Z
DTSTART:20220118T080000
LOCATION:Amba Marble Arch (Guoman)\, Bryanston Street\, London\, England\,
  W1H 7EH\,
SEQUENCE:0
SUMMARY:Address Key European Regulatory Challenges and Cutting Edge Platfo
 rm Design to Advance Allogeneic Approaches\nAllogeneic therapies are fast
  becomin...
UID:4b0873f1-fce0-48ed-bdff-6ab4ce333bc8
END:VEVENT
END:VCALENDAR